Michael W. Freeman
Stock Analyst at Raymond James
(2.30)
# 2,959
Out of 4,357 analysts
43
Total ratings
37.9%
Success rate
2.2%
Average return
Main Sectors:
Stocks Rated by Michael W. Freeman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: AIDX Healwell AI Inc. | Maintained: Buy | $3.00 → $2.50 | $0.90 | +177.78% | 5 | Mar 25, 2026 | |
| TSX: HLS HLS Therapeutics Inc. | Maintained: Buy | $6.00 → $7.00 | $4.59 | +52.51% | 2 | Nov 18, 2025 | |
| TSX: WELL WELL Health Technologies Corp. | Maintained: Buy | n/a | $4.38 | - | 5 | Nov 6, 2025 | |
| TSX: PRN Profound Medical Corp. | Maintained: Buy | $15.19 | $9.53 | +59.38% | 4 | Oct 8, 2025 | |
| TSX: MDP Medexus Pharmaceuticals Inc. | Maintained: Buy | $8.00 | $3.88 | +106.19% | 9 | Aug 14, 2025 | |
| TSX: VHI Vitalhub Corp. | Maintained: Buy | $14.50 → $15.00 | $7.48 | +100.53% | 6 | Aug 12, 2025 | |
| TSX: BHC Bausch Health Companies Inc. | Maintained: Hold | $11.05 | $7.41 | +49.08% | 7 | Aug 5, 2025 | |
| NGEN NervGen Pharma | Maintained: Buy | $3.26 → $4.35 | $2.07 | +109.91% | 3 | Jun 11, 2025 | |
| TSX: GUD Knight Therapeutics Inc. | Maintained: Buy | $8.00 | $8.19 | n/a | 1 | Mar 12, 2025 | |
| TSXV: PINK Perimeter Medical Imaging AI, Inc. | Upgraded: Buy | $1.50 | $0.315 | n/a | 1 | Nov 18, 2024 |
Healwell AI Inc.
Mar 25, 2026
Maintained: Buy
Price Target: $3.00 → $2.50
Current: $0.90
Upside: +177.78%
HLS Therapeutics Inc.
Nov 18, 2025
Maintained: Buy
Price Target: $6.00 → $7.00
Current: $4.59
Upside: +52.51%
WELL Health Technologies Corp.
Nov 6, 2025
Maintained: Buy
Price Target: n/a
Current: $4.38
Upside: -
Profound Medical Corp.
Oct 8, 2025
Maintained: Buy
Price Target: $15.19
Current: $9.53
Upside: +59.38%
Medexus Pharmaceuticals Inc.
Aug 14, 2025
Maintained: Buy
Price Target: $8.00
Current: $3.88
Upside: +106.19%
Vitalhub Corp.
Aug 12, 2025
Maintained: Buy
Price Target: $14.50 → $15.00
Current: $7.48
Upside: +100.53%
Bausch Health Companies Inc.
Aug 5, 2025
Maintained: Hold
Price Target: $11.05
Current: $7.41
Upside: +49.08%
NervGen Pharma
Jun 11, 2025
Maintained: Buy
Price Target: $3.26 → $4.35
Current: $2.07
Upside: +109.91%
Knight Therapeutics Inc.
Mar 12, 2025
Maintained: Buy
Price Target: $8.00
Current: $8.19
Upside: n/a
Perimeter Medical Imaging AI, Inc.
Nov 18, 2024
Upgraded: Buy
Price Target: $1.50
Current: $0.315
Upside: n/a